Published in J Virol on January 01, 1997
Evolutionary struggles between NK cells and viruses. Nat Rev Immunol (2008) 3.79
Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med (2001) 3.55
NK cell development, homeostasis and function: parallels with CD8⁺ T cells. Nat Rev Immunol (2011) 3.38
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med (2003) 2.75
Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med (1998) 2.53
Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol (2004) 2.43
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med (2001) 2.37
Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med (1998) 2.34
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med (2007) 2.32
Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev (2001) 1.97
Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest (2002) 1.83
Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J Virol (2002) 1.74
Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J Exp Med (2009) 1.70
Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J Exp Med (2000) 1.69
Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol (2001) 1.65
Does nitric oxide play a critical role in viral infections? J Virol (1998) 1.62
Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol (2005) 1.55
Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog (2010) 1.51
Adaptive immune responses mediated by natural killer cells. Immunol Rev (2010) 1.48
Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J Exp Med (1999) 1.47
Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc Natl Acad Sci U S A (1999) 1.46
Role of natural killer cells in innate protection against lethal ebola virus infection. J Exp Med (2004) 1.44
Specific remodeling of splenic architecture by cytomegalovirus. PLoS Pathog (2006) 1.43
Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis. J Virol (1999) 1.42
Regulation of inflammatory monocyte/macrophage recruitment from the bone marrow during murine cytomegalovirus infection: role for type I interferons in localized induction of CCR2 ligands. J Immunol (2009) 1.40
NK cell-like behavior of Valpha14i NK T cells during MCMV infection. PLoS Pathog (2008) 1.39
Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J Virol (2006) 1.35
Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J Virol (2003) 1.35
Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production. Blood (2008) 1.34
Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J Exp Med (2002) 1.33
Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J Immunol (2008) 1.33
CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection. J Virol (2006) 1.27
Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J Virol (1999) 1.22
Transcriptional regulation of innate lymphoid cell fate. Nat Rev Immunol (2015) 1.21
Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland. J Virol (2003) 1.18
Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything. J Intern Med (2010) 1.17
Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection. J Exp Med (2009) 1.16
ATF3 regulates MCMV infection in mice by modulating IFN-gamma expression in natural killer cells. Proc Natl Acad Sci U S A (2008) 1.13
The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiology. J Virol (1998) 1.13
Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes. Immunity (2012) 1.07
Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant. J Virol (1998) 1.05
Natural killer cell responses to viral infection. J Innate Immun (2011) 1.03
Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons. Am J Pathol (2002) 1.03
Vgamma1+ gammadelta T cells play protective roles at an early phase of murine cytomegalovirus infection through production of interferon-gamma. Immunology (2000) 1.02
Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infection. Hepatology (2005) 1.02
The role of natural killer cells in sepsis. J Biomed Biotechnol (2011) 1.02
Temporal effects of gamma interferon deficiency on the course of Friend retrovirus infection in mice. J Virol (2002) 1.01
Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J Virol (2010) 1.01
NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections. Virology (2013) 1.01
Integrin-mediated ras-extracellular regulated kinase (ERK) signaling regulates interferon gamma production in human natural killer cells. J Exp Med (1998) 1.00
NK cells: a double-edged sword in chronic hepatitis B virus infection. Front Immunol (2013) 1.00
The Critical Role of IL-15-PI3K-mTOR Pathway in Natural Killer Cell Effector Functions. Front Immunol (2014) 0.99
Respiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes. Am J Pathol (2003) 0.99
Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus. J Virol (2000) 0.97
IL-15-PI3K-AKT-mTOR: A Critical Pathway in the Life Journey of Natural Killer Cells. Front Immunol (2015) 0.93
The early kinetics of cytomegalovirus-specific CD8+ T-cell responses are not affected by antigen load or the absence of perforin or gamma interferon. J Virol (2008) 0.92
CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis. J Leukoc Biol (2008) 0.91
NK cell-activating receptors require PKC-theta for sustained signaling, transcriptional activation, and IFN-gamma secretion. Blood (2008) 0.91
IL-10 restricts activation-induced death of NK cells during acute murine cytomegalovirus infection. J Immunol (2011) 0.90
Differential requirements for CD45 in NK-cell function reveal distinct roles for Syk-family kinases. Blood (2011) 0.89
NK cells, innate immunity and hepatitis C infection after liver transplantation. Clin Infect Dis (2011) 0.86
Lymphoid-tissue stromal cells coordinate innate defense to cytomegalovirus. J Virol (2013) 0.86
Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infection. Med Microbiol Immunol (2012) 0.86
Natural killer cells in immunodefense against infective agents. Expert Rev Anti Infect Ther (2008) 0.86
m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J Exp Med (1999) 0.85
The role of innate immunity in HBV infection. Semin Immunopathol (2012) 0.85
CD28/B7-mediated co-stimulation is critical for early control of murine cytomegalovirus infection. Viral Immunol (2009) 0.85
Roles of natural killer cells in antiviral immunity. Curr Opin Virol (2015) 0.83
IL-10 mediated regulation of liver inflammation during acute murine cytomegalovirus infection. PLoS One (2012) 0.82
NK gene complex and chromosome 19 loci enhance MHC resistance to murine cytomegalovirus infection. Immunogenetics (2010) 0.82
UNC93B1 mediates innate inflammation and antiviral defense in the liver during acute murine cytomegalovirus infection. PLoS One (2012) 0.79
Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus. PLoS Pathog (2015) 0.78
Specific dysregulation of IFNγ production by natural killer cells confers susceptibility to viral infection. PLoS Pathog (2014) 0.77
The specific NK cell response in concert with perforin prevents CD8(+) T cell-mediated immunopathology after mouse cytomegalovirus infection. Med Microbiol Immunol (2015) 0.77
Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK Cells. PLoS Pathog (2015) 0.77
Immunoregulatory cytokine networks: 60 years of learning from murine cytomegalovirus. Med Microbiol Immunol (2015) 0.76
Identification of Mouse Cytomegalovirus Resistance Loci by ENU Mutagenesis. Viruses (2009) 0.75
Intrinsic Contribution of Perforin to NK-Cell Homeostasis during Mouse Cytomegalovirus Infection. Front Immunol (2016) 0.75
Redefining Memory: Building the Case for Adaptive NK cells. J Virol (2017) 0.75
Biology of natural killer cells. Adv Immunol (1989) 14.77
Nitric oxide as a secretory product of mammalian cells. FASEB J (1992) 13.38
Immune response in mice that lack the interferon-gamma receptor. Science (1993) 12.15
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (1994) 11.22
In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 10.84
Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity (1996) 8.27
Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med (1989) 7.52
A monoclonal antibody discriminating between subsets of T and B cells. J Immunol (1981) 6.15
Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science (1993) 4.80
Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A (1994) 4.06
Establishment of monoclonal anti-Nk-1.1 antibody. Hybridoma (1984) 3.68
Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J Exp Med (1985) 3.48
Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med (1995) 3.40
An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol (1996) 3.09
The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol (1993) 3.01
Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol (1984) 2.73
Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med (1990) 2.55
The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J Virol (1995) 2.45
Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl Acad Sci U S A (1981) 2.31
Importance of interferons in recovery from mousepox. J Virol (1993) 2.12
The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol (1992) 2.08
CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol (1994) 2.00
The role of natural killer cells in host-parasite interactions. Curr Opin Immunol (1995) 1.77
Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1. Genomics (1995) 1.76
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J Virol (1995) 1.74
Target structures involved in natural killing (NK): characteristics, distribution, and candidate molecules. Crit Rev Immunol (1991) 1.68
Natural killer cell receptors: the offs and ons of NK cell recognition. Cell (1995) 1.57
Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J Exp Med (1990) 1.56
Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection. J Gen Virol (1993) 1.51
Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J Virol (1995) 1.40
NK cell response to viral infections in beta 2-microglobulin-deficient mice. J Immunol (1995) 1.30
Natural killer cell receptors. Curr Opin Immunol (1995) 1.28
Recognition structures on natural killer cells. Curr Opin Immunol (1993) 1.24
Recognition of major histocompatibility complex class I antigens by natural killer cells. J Exp Med (1994) 1.23
Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice. J Immunol (1995) 1.20
Characteristics of infection of B and T lymphocytes from mice after inoculation with cytomegalovirus. Infect Immun (1979) 1.11
The BALB.B6-Cmv1r mouse: a strain congenic for Cmv1 and the NK gene complex. Immunogenetics (1995) 1.07
Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. J Immunol (1988) 1.03
Antiviral activity of NK 1.1+ natural killer cells in C57BL/6 scid mice infected with murine cytomegalovirus. Nat Immun (1995) 1.01
Chemotactic effect of human recombinant interleukin 2 on mouse activated large granular lymphocytes. J Immunol (1987) 0.92
Regulation of hematopoiesis in vitro by alloreactive natural killer cell clones. J Exp Med (1993) 0.91
The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol (1980) 6.24
Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol (2001) 3.59
Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol (1983) 3.58
Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med (2001) 3.55
Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J Exp Med (1985) 3.48
Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med (1978) 3.31
Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J Exp Med (1994) 2.87
Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol (1984) 2.73
Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity (1999) 2.55
Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med (1998) 2.53
Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J Exp Med (1976) 2.34
CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection. J Immunol (1992) 2.32
High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J Exp Med (1993) 2.20
Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J Exp Med (1996) 2.14
Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J Immunol (1989) 2.13
Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice. Nature (1977) 2.05
Widespread occurrence and genetic diversity of marine parasitoids belonging to Syndiniales (Alveolata). Environ Microbiol (2008) 2.01
Apoptosis in viral infections. Adv Virus Res (1995) 1.97
Some ultrastructural effects of persistent infections by the rickettsia Coxiella burnetii in mouse L cells and green monkey kidney (Vero) cells. Infect Immun (1978) 1.96
Restriction specificities, alloreactivity, and allotolerance expressed by T cells from nude mice reconstituted with H-2-compatible or -incompatible thymus grafts. J Exp Med (1980) 1.96
Stability and diversity of T cell receptor repertoire usage during lymphocytic choriomeningitis virus infection of mice. J Exp Med (1998) 1.93
Human serum lyses RNA tumour viruses. Nature (1975) 1.92
Mouse natural killer cells: induction specificity, and function. J Immunol (1978) 1.89
Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J Virol (2001) 1.87
Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol (1993) 1.85
Induction of alloreactive cytotoxic T cells by acute virus infection of mice. J Immunol (1986) 1.84
Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J Exp Med (1997) 1.74
Blastogenesis of natural killer cells during viral infection in vivo. J Immunol (1982) 1.72
Long-term persistent vesicular stomatitis virus and rabies virus infection of cells in vitro. J Gen Virol (1976) 1.71
Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells. Immunity (2001) 1.69
Regulation of virus infections by natural killer cells. A review. Nat Immun Cell Growth Regul (1986) 1.68
Increase in NK cell number and turnover rate during acute viral infection. J Immunol (1983) 1.65
On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. J Immunol (1980) 1.62
Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J Immunol (2001) 1.60
In vivo state of antiviral CTL precursors. Characterization of a cycling cell population containing CTL precursors in immune mice. J Immunol (1995) 1.52
Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J Exp Med (1998) 1.50
Natural killer cells and interferon. Crit Rev Immunol (1984) 1.49
Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells. J Exp Med (1985) 1.49
T-cell-independent antiviral antibody responses. Curr Opin Immunol (1998) 1.49
Inhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expression. J Exp Med (1977) 1.49
Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am J Pathol (1995) 1.48
Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication. J Immunol (1987) 1.43
Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection. J Exp Med (1986) 1.43
Determinants of lymphocytic choriomeningitis interference. J Gen Virol (1972) 1.41
Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J Virol (1995) 1.40
Natural cell-mediated immunity during viral infections. Curr Top Microbiol Immunol (1981) 1.40
Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science (1991) 1.37
Alterations of acetylcholine enzymes in neuroblastoma cells persistently infected with lymphocytic choriomeningitis virus. J Cell Physiol (1977) 1.37
Detection of a high frequency of virus-specific CD4+ T cells during acute infection with lymphocytic choriomeningitis virus. J Immunol (1998) 1.36
Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus. J Immunol (1983) 1.35
Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection. J Immunol (1997) 1.33
Generation of large granular T lymphocytes in vivo during viral infection. J Immunol (1986) 1.33
Apoptotic regulation of T cells and absence of immune deficiency in virus-infected gamma interferon receptor knockout mice. J Virol (1998) 1.32
NK cell response to viral infections in beta 2-microglobulin-deficient mice. J Immunol (1995) 1.30
Natural killer cell response to lymphocytic choriomeningitis virus in beige mice. Scand J Immunol (1980) 1.30
Interferon induces natural killer cell blastogenesis in vivo. J Leukoc Biol (1984) 1.30
T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J Exp Med (1996) 1.29
Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype. J Immunol (1986) 1.29
Stability of virus-specific CD4+ T cell frequencies from acute infection into long term memory. J Immunol (1998) 1.29
Effect of virus infections on target cell susceptibility to natural killer cell-mediated lysis. J Immunol (1980) 1.27
Antibody-complement interactions with purified lymphocytic choriomeningitis virus. Virology (1976) 1.27
Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J Immunol (1995) 1.27
Inactivation of lysis of oncornaviruses by human serum. Virology (1976) 1.26
Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. II. "Specificities" of the natural killer cells. J Immunol (1979) 1.24
Amantadine hydrochloride inhibition of early and late stages of lymphocytic choriomenigitis virus-cell interactions. Virology (1971) 1.23
Host cell modification of lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement. J Immunol (1977) 1.21
Control of infections by NK cells. Curr Top Microbiol Immunol (1998) 1.20
The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J Immunol (1986) 1.20
Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo. J Immunol (1985) 1.19
T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J Virol (1996) 1.18
Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: relative stability of CD4 memory under conditions of CD8 memory T cell loss. J Immunol (2001) 1.18
High frequency of virus-specific interleukin-2-producing CD4(+) T cells and Th1 dominance during lymphocytic choriomeningitis virus infection. J Virol (2000) 1.16
Protein analysis of defective interfering lymphocytic choriomeningitis virus and persistently infected cells. Virology (1979) 1.15
Interferon-mediated protection of normal and tumor target cells against lysis by mouse natural killer cells. J Immunol (1981) 1.14
Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression. J Virol (2000) 1.13
Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target. J Exp Med (1994) 1.12
Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes. J Immunol (1986) 1.12
Arenaviruses: cellular response to long-term in vitro infection with parana and lymphocytic choriomeningitis viruses. Infect Immun (1972) 1.10
Specificity and editing by apoptosis of virus-induced cytotoxic T lymphocytes. Curr Opin Immunol (1994) 1.10
Properties of defective lymphocytic choriomeningitis virus. J Gen Virol (1972) 1.08
Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice. Nat Immun Cell Growth Regul (1985) 1.07
Separation and isolation of rat natural killer (NK) cells from T cells with monoclonal antibodies. J Immunol (1984) 1.06
Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice. Nature (1977) 1.05
The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. J Immunol (1999) 1.05
Activation and role of natural killer cells in virus infections. Med Microbiol Immunol (1982) 1.04
T-Cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles. J Virol (1998) 1.03
Necrosis of adipose tissue induced by sequential infections with unrelated viruses. Am J Pathol (1985) 1.00
Effects of virally expressed interleukin-10 on vaccinia virus infection in mice. J Virol (1993) 1.00
Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells. Virology (2001) 1.00
Antiviral effect of lymphokine-activated killer cells: characterization of effector cells mediating prophylaxis. J Virol (1988) 0.99
A comparative analysis of the cell surface properties of activated vs endogenous mouse natural killer cells. J Immunol (1980) 0.99
Infection of peripancreatic lymph nodes but not islets precedes Kilham rat virus-induced diabetes in BB/Wor rats. J Virol (1993) 0.99
Correlation of glycosphingolipids and sialic acid in YAC-1 lymphoma variants with their sensitivity to natural killer-cell-mediated lysis. Int J Cancer (1981) 0.97
A comparison of biochemical and biological properties of standard and defective lymphocytic choriomeningitis virus. Bull World Health Organ (1975) 0.95
Role of natural killer cells in virus infections of mice. Surv Synth Pathol Res (1984) 0.95
Exquisite specificity of adoptive immunization in arenavirus-infected mice. Antiviral Res (1985) 0.94